Interestingly, Vlachostergios et al found that BTZ may overcome MGMT-related chemoresistance of GBM cells to TMZ in a schedule-dependent manner through interfering NF-κB, MAPK, STAT3 and HIF-1α signaling pathway19. Here, STAT3 is linked to glioblastoma.